Russia’s “foreign agent” law, established in 2012 to identify individuals and organizations that received international funding, has become a tool to criminally prosecute and ban from public life ...
Despite significant R&D investments, pharma companies often underestimate the multifaceted challenges of bringing promising treatments to market – from securing favourable reimbursement to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback